Menicon Co., Ltd.

7780.T
Medical Instruments & Supplies
2026/08/21 Updated
Market Cap: $906.6M (¥144.1B)
Stock Price: $12.21 (¥1,941)
Exchange Rate: 1 USD = ¥158.98

[Menicon] Decision to Grant Stock Compensation-Type Stock Options | June 2026

Menicon has decided to grant stock options to executive officers, directors, and employees on June 26, 2026. The total number of allocated shares is 44,600, with the allocation date on August 3, 2026. The exercise period for the stock options is from March 31, 2027, to March 30, 2077.

Importance:
Page Updated: June 26, 2026
IR Disclosure Date: June 26, 2026

Key Figures

  • Total Number of Stock Options: 446 units
  • Number of Shares Granted: 44,600 shares
  • Allocation Date: August 3, 2026

AI要約

Grant Details and Purpose

At the Board of Directors meeting held on June 26, 2026, Menicon decided to grant stock compensation-type stock options to executive officers, directors (excluding outside directors), and employees. The total number of shares allocated is 44,600, with the allocation date set as August 3, 2026. The exercise period for the stock options spans from March 31, 2027, to March 30, 2077, aiming to enhance corporate value and boost employee morale through the issuance of shares. The details regarding the number of shares granted and exercise conditions are extensively specified, including provisions for adjustments and reorganization scenarios.

Shareholders and Future Outlook

This stock option grant is positioned as a measure to strengthen commitment from employees and directors towards the company, aiming for long-term corporate value enhancement. The strict regulations on the number of shares granted and exercise conditions are expected to limit dilution impacts on shareholders. Going forward, the company plans to continue promoting incentive plans and capital policies aligned with its growth strategies.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Menicon Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →